Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

At this stage in the COVID-19 pandemic, most infections are "breakthrough" infections that occur in individuals with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. To refine long-term vaccine strategies against emerging variants, we examined both innate and adaptive immunity in breakthrough infections. We performed single-cell transcriptomic, proteomic, and functional profiling of primary and breakthrough infections to compare immune responses from unvaccinated and vaccinated individuals during the SARS-CoV-2 Delta wave. Breakthrough infections were characterized by a less activated transcriptomic profile in monocytes and natural killer cells, with induction of pathways limiting monocyte migratory potential and natural killer cell proliferation. Furthermore, we observed a female-specific increase in transcriptomic and proteomic activation of multiple innate immune cell subsets during breakthrough infections. These insights suggest that prior SARS-CoV-2 vaccination prevents overactivation of innate immune responses during breakthrough infections with discernible sex-specific patterns and underscore the potential of harnessing vaccines in mitigating pathologic immune responses resulting from overactivation.

Authors

Institutions

Publication Details

Journal
Science Translational Medicine
Published
2025-01-29
DOI
https://doi.org/10.1126/scitranslmed.adq1086
Citations
18
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
14.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Madeline J. Lee, Susan Holmes, Wenming Zhang, Elizabeth J. Zudock et al.
18 citations
Science Translational Medicine
Immune responses and vaccinations
14.35
article

Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Madeline J. Lee, Susan Holmes, Wenming Zhang, Elizabeth J. Zudock, Ruth O’Hara, Kassandra Pinedo, Ruoxi Pi, Rosen Mann, Samuel Yang, Drina Bogusch, Donald Schreiber, Rebecca E. Hamlin, Komal Kumar, Michal Caspi Tal, Mikayla A. Stabile, James Quinn, Nimish Kathale, Kari Christine Nadeau, Jennifer A. Newberry, Maureen Caracena Ty, Kalani Ratnasiri, Hena Din, Taylor Hollis, Shu‐Chen Lyu, Bali Pulendran, Evan Do, Nancy Q. Zhao, Leslie Chan, Rosemary Vergara, Anita Visweswaran, Andra L. Blomkalns, Michele Ugur, Jonasel Roque, Kathleen D. Press, Monali Manohar, James Krempski, Lauren de la Parte, Giovanny J. Martínez-Colón, Angela J. Rogers, Kathryn Jee, Laura J. Simpson, Euan Angus Ashley, Iris Chang, Andrea Baird, Catherine A. Blish, Arjun Rustagi, Julia L. McKechnie, Thanmayi Ranganath, Kazim Haider, Andrea Fernandes, Aaron J. Wilk, Georgie Nahass, Rachel Brewer, Geoffrey T. Ivison, S. Pienkos, Kim Q.T. Tran
article en
18 citations

Abstract

At this stage in the COVID-19 pandemic, most infections are "breakthrough" infections that occur in individuals with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. To refine long-term vaccine strategies against emerging variants, we examined both innate and adaptive immunity in breakthrough infections. We performed single-cell transcriptomic, proteomic, and functional profiling of primary and breakthrough infections to compare immune responses from unvaccinated and vaccinated individuals during the SARS-CoV-2 Delta wave. Breakthrough infections were characterized by a less activated transcriptomic profile in monocytes and natural killer cells, with induction of pathways limiting monocyte migratory potential and natural killer cell proliferation. Furthermore, we observed a female-specific increase in transcriptomic and proteomic activation of multiple innate immune cell subsets during breakthrough infections. These insights suggest that prior SARS-CoV-2 vaccination prevents overactivation of innate immune responses during breakthrough infections with discernible sex-specific patterns and underscore the potential of harnessing vaccines in mitigating pathologic immune responses resulting from overactivation.

Science Translational MedicineVol. 17(783)
Harvard University (US), Chan Zuckerberg Initiative (United States) (US), Stanford University (US)
Bill and Melinda Gates Foundation, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 1%
Immune responses and vaccinations
14.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.